199 related articles for article (PubMed ID: 22382829)
21. [The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy].
Mizukami Y; Sato J; Nihei S; Kashiwaba M; Kudo K; Okuyama H; Tamura K
Gan To Kagaku Ryoho; 2016 Aug; 43(8):979-83. PubMed ID: 27539040
[TBL] [Abstract][Full Text] [Related]
22. Effect of polaprezinc on healing of acetic acid-induced stomatitis in hamsters.
Katayama S; Nishizawa K; Hirano M; Yamamura S; Momose Y
J Pharm Pharm Sci; 2000; 3(1):114-7. PubMed ID: 10954680
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the cellular actions of polaprezinc (zinc-L-carnosine) and ZnCl2.
Seo H; Ogata-Ikeda I; Ishida S; Okano Y; Oyama Y
Life Sci; 2012 Jun; 90(25-26):1015-9. PubMed ID: 22683432
[TBL] [Abstract][Full Text] [Related]
24. Taste disorders: a survey of the examination methods and treatments used in Japan.
Ikeda M; Aiba T; Ikui A; Inokuchi A; Kurono Y; Sakagami M; Takeda N; Tomita H
Acta Otolaryngol; 2005 Nov; 125(11):1203-10. PubMed ID: 16353402
[TBL] [Abstract][Full Text] [Related]
25. Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells.
Fuji Y; Matsura T; Kai M; Kawasaki H; Yamada K
Jpn J Pharmacol; 2000 Sep; 84(1):63-70. PubMed ID: 11043455
[TBL] [Abstract][Full Text] [Related]
26. Polaprezinc exerts a salutary effect on impaired healing of acute gastric lesions in diabetic rats.
Korolkiewicz RP; Fujita A; Seto K; Suzuki K; Takeuchi K
Dig Dis Sci; 2000 Jun; 45(6):1200-9. PubMed ID: 10877238
[TBL] [Abstract][Full Text] [Related]
27. Protection by polaprezinc against radiation-induced apoptosis in rat jejunal crypt cells.
Matsuu-Matsuyama M; Shichijo K; Okaichi K; Nakayama T; Nakashima M; Uemura T; Niino D; Sekine I
J Radiat Res; 2008 Jul; 49(4):341-7. PubMed ID: 18413982
[TBL] [Abstract][Full Text] [Related]
28. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
[TBL] [Abstract][Full Text] [Related]
29. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.
Sakae K; Suka M; Yanagisawa H
J Clin Psychopharmacol; 2020; 40(6):599-606. PubMed ID: 33044355
[TBL] [Abstract][Full Text] [Related]
30. Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats--role of insulin-like growth factors (IGF)-1.
Kato S; Tanaka A; Ogawa Y; Kanatsu K; Seto K; Yoneda T; Takeuchi K
Med Sci Monit; 2001; 7(1):20-5. PubMed ID: 11208487
[TBL] [Abstract][Full Text] [Related]
31. The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide.
Choi HS; Lim JY; Chun HJ; Lee M; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS; Sul D
Life Sci; 2013 Jul; 93(2-3):69-77. PubMed ID: 23743168
[TBL] [Abstract][Full Text] [Related]
32. Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy.
Hayashi H; Kobayashi R; Suzuki A; Yamada Y; Ishida M; Shakui T; Kitagawa J; Hayashi H; Sugiyama T; Takeuchi H; Tsurumi H; Itoh Y
Med Oncol; 2016 Aug; 33(8):91. PubMed ID: 27418192
[TBL] [Abstract][Full Text] [Related]
33. Induction of type 1 interferon receptor by zinc in U937 cells.
Nagamine T; Nakajima K; Takada H; Sekine Y; Suzuki K
Cytokine; 2009 Jun; 46(3):346-50. PubMed ID: 19362011
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of polaprezinc on cadmium-induced injury of lung epithelium.
Kimura K; Nakano Y; Sugizaki T; Shimoda M; Kobayashi N; Kawahara M; Tanaka KI
Metallomics; 2019 Jul; 11(7):1310-1320. PubMed ID: 31236550
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of polaprezinc on the inflammatory response to Helicobacter pylori.
Handa O; Yoshida N; Tanaka Y; Ueda M; Ishikawa T; Takagi T; Matsumoto N; Naito Y; Yoshikawa T
Can J Gastroenterol; 2002 Nov; 16(11):785-9. PubMed ID: 12464972
[TBL] [Abstract][Full Text] [Related]
36. Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro.
Hiraishi H; Sasai T; Oinuma T; Shimada T; Sugaya H; Terano A
Aliment Pharmacol Ther; 1999 Feb; 13(2):261-9. PubMed ID: 10102958
[TBL] [Abstract][Full Text] [Related]
37. Importance of luminal and mucosal zinc in the mechanism of experimental gastric ulcer healing.
Opoka W; Adamek D; Plonka M; Reczynski W; Bas B; Drozdowicz D; Jagielski P; Sliwowski Z; Adamski P; Brzozowski T
J Physiol Pharmacol; 2010 Oct; 61(5):581-91. PubMed ID: 21081802
[TBL] [Abstract][Full Text] [Related]
38. Effects of zinc supplementation on serum zinc concentration and ratio of apo/holo-activities of angiotensin converting enzyme in patients with taste impairment.
Takaoka T; Sarukura N; Ueda C; Kitamura Y; Kalubi B; Toda N; Abe K; Yamamoto S; Takeda N
Auris Nasus Larynx; 2010 Apr; 37(2):190-4. PubMed ID: 19716667
[TBL] [Abstract][Full Text] [Related]
39. Oral zinc therapy for zinc deficiency-related telogen effluvium.
Karashima T; Tsuruta D; Hamada T; Ono F; Ishii N; Abe T; Ohyama B; Nakama T; Dainichi T; Hashimoto T
Dermatol Ther; 2012; 25(2):210-3. PubMed ID: 22741940
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Himoto T; Hosomi N; Nakai S; Deguchi A; Kinekawa F; Matsuki M; Yachida M; Masaki T; Kurokochi K; Watanabe S; Senda S; Kuriyama S
Scand J Gastroenterol; 2007 Sep; 42(9):1078-87. PubMed ID: 17710674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
